Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL)

Summary

The goal of this clinical research study is to determine the effectiveness of alemtuzumab in patients with aplastic anemia, MDS, or T-Cell large granular lymphocytic leukemia. The safety of alemtuzumab will also be studied.

Timeline

Start

2010-08

Primary completion

2013-11

Completion

2013-11

Outcome

Outcome not reported

Stopped (Enrollment): “Low Accrual”

Drugs

Indications